• Paris+33 (0)1 82 73 24 63

    • Fr
    • En
  • PharmaBlue
    • About PharmaBlue
    • Quality Policy
    • Working with PharmaBlue
    • Our Team
  • Exploitant Services
    • About Exploitant status
    • Our Exploitant Services
  • Early Access Program Services
    • About Early Access in France
    • Our EAP Services
  • Resources
  • Blog Posts
  • Careers
  • Contact us

page

Cancel reply

You must be logged in to post a comment.

Recent Posts

  • Everything to know about exploitant status in France
  • Benefits of using a third party Exploitant to run early access programs in France and more
  • How to take advantage of early access programs for your innovative treatments in France?
  • 9 Must-knows for US biotechs looking to enter the EU Market

Recent Comments

    Archives

    • June 2023
    • May 2023
    • April 2023

    Categories

    • Blog Posts
    • Non classé

    Get in touch with our experts

    Send us a message

    About us

    Welcome to PharmaBlue a PharmaLex company. PharmaBlue is a partner “Exploitant” of innovative Pharma Companies for the marketing in France of their medicinal products which have been granted an Early access authorization (EAP previously ATU) or a Marketing Authorization (MA)

     

    PharmaBlue holds an “Etablissement Pharmaceutique Exploitant” license from ANSM and can take over the organisation and supervision of the distribution in France of pharmaceuticals products.

    Links

    • Affiliations and partnerships
    • News
    • Careers
    • Terms of use
    • Data Privacy

    Get in touch